Certified professionals: CD4(+)CD25(+) suppressor T cells - PubMed (original) (raw)

Certified professionals: CD4(+)CD25(+) suppressor T cells

E M Shevach. J Exp Med. 2001.

No abstract available

PubMed Disclaimer

Similar articles

• Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood.
  Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Dieckmann D, et al. J Exp Med. 2001 Jun 4;193(11):1303-10. doi: 10.1084/jem.193.11.1303. J Exp Med. 2001. PMID: 11390437 Free PMC article.
• The role of regulatory T lymphocytes in asthma pathogenesis.
  Robinson DS. Robinson DS. Curr Allergy Asthma Rep. 2005 Mar;5(2):136-41. doi: 10.1007/s11882-005-0087-8. Curr Allergy Asthma Rep. 2005. PMID: 15683614 Review.
• Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance.
  Graca L, Thompson S, Lin CY, Adams E, Cobbold SP, Waldmann H. Graca L, et al. J Immunol. 2002 Jun 1;168(11):5558-65. doi: 10.4049/jimmunol.168.11.5558. J Immunol. 2002. PMID: 12023351
• Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function.
  Thornton AM, Donovan EE, Piccirillo CA, Shevach EM. Thornton AM, et al. J Immunol. 2004 Jun 1;172(11):6519-23. doi: 10.4049/jimmunol.172.11.6519. J Immunol. 2004. PMID: 15153463
• The role of self-peptides in the development of CD4+ CD25+ regulatory T cells.
  Picca CC, Caton AJ. Picca CC, et al. Curr Opin Immunol. 2005 Apr;17(2):131-6. doi: 10.1016/j.coi.2005.01.003. Curr Opin Immunol. 2005. PMID: 15766671 Review.

Cited by

• Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata.
  Zöller M, Freyschmidt-Paul P, Vitacolonna M, McElwee KJ, Hummel S, Hoffmann R. Zöller M, et al. Clin Exp Immunol. 2004 Mar;135(3):398-408. doi: 10.1111/j.1365-2249.2003.02380.x. Clin Exp Immunol. 2004. PMID: 15008971 Free PMC article.
• Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells.
  Dannull J, Su Z, Rizzieri D, Yang BK, Coleman D, Yancey D, Zhang A, Dahm P, Chao N, Gilboa E, Vieweg J. Dannull J, et al. J Clin Invest. 2005 Dec;115(12):3623-33. doi: 10.1172/JCI25947. Epub 2005 Nov 23. J Clin Invest. 2005. PMID: 16308572 Free PMC article. Clinical Trial.
• PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer.
  Baratelli F, Lee JM, Hazra S, Lin Y, Walser TC, Schaue D, Pak PS, Elashoff D, Reckamp K, Zhang L, Fishbein MC, Sharma S, Dubinett SM. Baratelli F, et al. Am J Transl Res. 2010 Jun 30;2(4):356-67. Am J Transl Res. 2010. PMID: 20733946 Free PMC article.
• Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells.
  Bour-Jordan H, Bluestone JA. Bour-Jordan H, et al. Immunol Rev. 2009 May;229(1):41-66. doi: 10.1111/j.1600-065X.2009.00775.x. Immunol Rev. 2009. PMID: 19426214 Free PMC article. Review.
• Improving engraftment and immune reconstitution in umbilical cord blood transplantation.
  Danby R, Rocha V. Danby R, et al. Front Immunol. 2014 Feb 24;5:68. doi: 10.3389/fimmu.2014.00068. eCollection 2014. Front Immunol. 2014. PMID: 24605111 Free PMC article. Review.

References

1. 1. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995;160:1151–1164. - PubMed
2. 1. Asano M., Toda M., Sakaguchi N., Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 1996;184:387–396. - PMC - PubMed
3. 1. Suri-Payer E., Amar A.Z., Thornton A.M., Shevach E.M. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 1998;160:1212–1218. - PubMed
4. 1. Thornton A.M., Shevach E.M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 1998;188:287–296. - PMC - PubMed
5. 1. Read S., Mauze S., Asseman C., Bean A., Coffman R., Powrie F. CD38CD45RBlow T cellsa population of T cells with immune regulatory activities in vitro. Eur. J. Immunol. 1998;28:3435–3447. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program